Esnault, C.; Schrama, D.; Houben, R.; Guyétant, S.; Desgranges, A.; Martin, C.; Berthon, P.; Viaud-Massuard, M.-C.; Touzé, A.; Kervarrec, T.;
et al. Antibody–Drug Conjugates as an Emerging Therapy in Oncodermatology. Cancers 2022, 14, 778.
https://doi.org/10.3390/cancers14030778
AMA Style
Esnault C, Schrama D, Houben R, Guyétant S, Desgranges A, Martin C, Berthon P, Viaud-Massuard M-C, Touzé A, Kervarrec T,
et al. Antibody–Drug Conjugates as an Emerging Therapy in Oncodermatology. Cancers. 2022; 14(3):778.
https://doi.org/10.3390/cancers14030778
Chicago/Turabian Style
Esnault, Clara, David Schrama, Roland Houben, Serge Guyétant, Audrey Desgranges, Camille Martin, Patricia Berthon, Marie-Claude Viaud-Massuard, Antoine Touzé, Thibault Kervarrec,
and et al. 2022. "Antibody–Drug Conjugates as an Emerging Therapy in Oncodermatology" Cancers 14, no. 3: 778.
https://doi.org/10.3390/cancers14030778
APA Style
Esnault, C., Schrama, D., Houben, R., Guyétant, S., Desgranges, A., Martin, C., Berthon, P., Viaud-Massuard, M.-C., Touzé, A., Kervarrec, T., & Samimi, M.
(2022). Antibody–Drug Conjugates as an Emerging Therapy in Oncodermatology. Cancers, 14(3), 778.
https://doi.org/10.3390/cancers14030778